Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers - Alessandro Rizzo, Antonio Cusmai, Raffaella Massafra, Samantha Bove, Maria Colomba Comes, Annarita Fanizzi, Gennaro
Table 2 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype | npj Breast Cancer
Frequency of Luminal A and Luminal B Breast Cancers in Pakistani Population | Semantic Scholar
Ki-67 evaluation in breast cancer: The daily diagnostic practice
Proposed Surrogate IHC Markers for Classification of Luminal B Breast... | Download Table
Biomedicines | Free Full-Text | Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
Envision Communications on X: "Doctors use genetic information about breast cancer cells to categorize breast cancers and help guide decisions about which treatments are best. Did you know Luminal B breast cancers
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
Cancers | Free Full-Text | Valproic Acid and Breast Cancer: State of the Art in 2021
Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype | BMC Research Notes | Full Text
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Breast cancer - The Lancet
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression | Molecular Diagnosis & Therapy
Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar
Incidence of breast cancer subtypes in Belgium: a population-based study - BJMO
CORALLEEN phase 2 trial: Neoadjuvant Ribociclib plus Letrozole in Early Stage HR positive, Her2 negative, Luminal
Luminal B Breast Cancer - an overview | ScienceDirect Topics
Subtypes of Breast Cancer - Breast Cancer - NCBI Bookshelf
Team:ZJU-China/Background - 2020.igem.org
Molecular classification of breast cancer subtypes. | Download Table
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients - Wang - 2020 - Cancer Medicine - Wiley Online Library
PinPointcases - INACTIVE --- Adjuvant systemic treatment of luminal A/B early breast cancer
Survival curves in the luminal A (a), luminal B (b), HER2 (c), and... | Download Scientific Diagram
